
c-RET
c-RET inhibitors target the RET (Rearranged during Transfection) proto-oncogene, which encodes a receptor tyrosine kinase involved in cell growth, differentiation, and survival. Abnormal activation of RET signaling can lead to uncontrolled cell proliferation and resistance to apoptosis, contributing to the development of cancers such as medullary thyroid carcinoma and non-small cell lung cancer. Inhibiting c-RET can induce apoptosis in cancer cells and is a promising approach in targeted cancer therapy. At CymitQuimica, we offer a variety of high-quality c-RET inhibitors to support your research in oncology, signal transduction, and apoptosis.
Found 51 products of "c-RET"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Selpercatinib
CAS:<p>"Selpercatinib (LOXO-292) is a RET tyrosine kinase inhibitor with IC50s of 14.0, 24.1, 530.7 nM for different RET mutations."</p>Formula:C29H31N7O3Purity:99.89% - >99.99%Color and Shape:SolidMolecular weight:525.6Pyrazoloadenine
CAS:<p>Pyrazoloadenine (4-Aminopyrazolo[3,4-d]pyrimidine) is the inhibitor of human xanthine oxidase.</p>Formula:C5H5N5Purity:99.02%Color and Shape:Beige PowderMolecular weight:135.13BBT594
CAS:<p>BBT594 (NVP-BBT594)(NVP-BBT594) is a potent inhibitor of receptor tyrosine kinase RET,Treatment of cancer.</p>Formula:C28H30F3N7O3Purity:99.57%Color and Shape:SolidMolecular weight:569.58SPP-86
CAS:<p>SPP-86 is an effective and selective cell-permeable inhibitor of RET tyrosine kinase with an IC50 of 8 nM.</p>Formula:C16H15N5Purity:99.53%Color and Shape:SolidMolecular weight:277.32RET V804M-IN-1
CAS:<p>RET V804M-IN-1 (RETV804M kinase inhibitor) is a wt-RET -selective RETV804M kinase inhibitors(IC50 = 20 nM).</p>Formula:C19H16N6OPurity:97.94% - 99.62%Color and Shape:SolidMolecular weight:344.37WHI-P180 hydrochloride
CAS:<p>WHI-P180 (Janex 3) inhibits RET, KDR and EGFR with IC50 values of 5 nM, 66 nM and 4 μM, respectively. WHI-P180 is a multi-kinase inhibitor.</p>Formula:C16H16ClN3O3Color and Shape:SolidMolecular weight:333.77RET-IN-22
CAS:<p>RET-IN-22 (compound 17b) is a potent, selective, and orally active inhibitor of RET, exhibiting IC50 values of 20.9 nM for wild-type RET and 18.3 nM for RET-</p>Formula:C29H31F3N6O4Color and Shape:SolidMolecular weight:584.59RET-IN-15
CAS:<p>RET-IN-15 is an inhibitor of rearrangement kinase (RET) during transfection and can be used in cancer research.</p>Formula:C27H28N8O2Color and Shape:SolidMolecular weight:496.56RET-IN-6
CAS:<p>RET-IN-6 is a potent inhibitor of RET (IC50: 4.57 nM).</p>Formula:C30H29N7Color and Shape:SolidMolecular weight:487.6DUN73423
CAS:<p>DUN73423 (RET-IN-21) is a potent tyrosine kinase (RET) inhibitor with antitumour activity for the study of cancer.</p>Formula:C19H16N6OPurity:98.09%Color and Shape:SolidMolecular weight:344.37RET-IN-8
CAS:<p>RET-IN-8 is an inhibitor of rearrangement kinase (RET) during transfection and can be used in cancer research.</p>Formula:C27H30N6O3Color and Shape:SolidMolecular weight:486.57TRK II-IN-1
CAS:<p>TRK II-IN-1: potent type II TRK inhibitor; IC50s: TRKA (3.3 nM), TRKB (6.4 nM), TRKC (4.3 nM), TRKA G667C (9.4 nM); also targets FLT3, RET, VEGFR2.</p>Formula:C29H31F3N8OPurity:98%Color and Shape:SolidMolecular weight:564.6RET-IN-16
CAS:<p>RET-IN-16: Selective RET inhibitor, IC50s 3.98-15.05 nM for various RET mutations; anticancer properties.</p>Formula:C31H29F3N8O2Color and Shape:SolidMolecular weight:602.61RET-IN-12
CAS:<p>RET-IN-12 is a RET inhibitor capable of acting on RET(WT) (IC50: 0.3 nM) and RET(V804M) (IC50: 1 nM).</p>Formula:C30H30F3N5O4Color and Shape:SolidMolecular weight:581.59RET-IN-23
CAS:<p>RET-IN-23 is an orally available and highly potent RET inhibitor with significant antitumor activity for the study of non-small cell lung cancer.</p>Formula:C28H28FN11Purity:97.46%Color and Shape:SolidMolecular weight:537.59RET-IN-3
CAS:<p>RET-IN-3 is a RETV804M kinase inhibitor with potential anticancer activity for the study of non-small cell lung cancer.</p>Formula:C18H21N5O2Purity:99.52%Color and Shape:SolidMolecular weight:339.39RET-IN-25
CAS:<p>RET-IN-25 (compound 6b) is an anticancer RET kinase inhibitor that demonstrates efficacy against medullary thyroid carcinoma (MTC), exhibiting half-maximal</p>Formula:C22H17N3O5SColor and Shape:SolidMolecular weight:435.45RET-IN-17
CAS:<p>RET-IN-17 inhibits RET kinase; may help in IBS pain and RET-activated cancers.</p>Formula:C27H28F4N4O4Color and Shape:SolidMolecular weight:548.53Vepafestinib
CAS:<p>Vepafestinib is a RET inhibitor with potential antineoplastic activity[1].</p>Formula:C26H30N6O3Purity:98.56%Color and Shape:SolidMolecular weight:474.55RET-IN-24
CAS:<p>RET-IN-24 (Compound 26) is a selective inhibitor of RET tyrosine kinase, demonstrating antitumor activity [1].</p>Formula:C27H26F2N8OColor and Shape:SolidMolecular weight:516.55
